Your browser doesn't support javascript.
loading
A specific molecular signature in SARS-CoV-2-infected kidney biopsies.
Isnard, Pierre; Vergnaud, Paul; Garbay, Serge; Jamme, Matthieu; Eloudzeri, Maeva; Karras, Alexandre; Anglicheau, Dany; Galantine, Valérie; Jalal Eddine, Arwa; Gosset, Clément; Pourcine, Franck; Zarhrate, Mohammed; Gibier, Jean-Baptiste; Rensen, Elena; Pietropaoli, Stefano; Barba-Spaeth, Giovanna; Duong-Van-Huyen, Jean-Paul; Molina, Thierry J; Mueller, Florian; Zimmer, Christophe; Pontoglio, Marco; Terzi, Fabiola; Rabant, Marion.
Afiliación
  • Isnard P; University of Paris Cité, INSERM U1151, CNRS UMR 8253, Institut Necker-Enfants Malades, Département Croissance et Signalisation, Paris, France.
  • Vergnaud P; Department of Pathology, Centre Hospitalier Universitaire Necker-Enfants Malades, Assistance Publique - Hopitaux de Paris (AP-HP), Paris, France.
  • Garbay S; University of Paris Cité, INSERM U1151, CNRS UMR 8253, Institut Necker-Enfants Malades, Département Croissance et Signalisation, Paris, France.
  • Jamme M; University of Paris Cité, INSERM U1151, CNRS UMR 8253, Institut Necker-Enfants Malades, Département Croissance et Signalisation, Paris, France.
  • Eloudzeri M; Department of Intensive Care Medicine, Centre Hospitalier Intercommunal de Poissy, Poissy, France.
  • Karras A; University of Paris Cité, INSERM U1151, CNRS UMR 8253, Institut Necker-Enfants Malades, Département Croissance et Signalisation, Paris, France.
  • Anglicheau D; Department of Nephrology, Centre Hospitalier Universitaire Européen Georges Pompidou, Paris, France.
  • Galantine V; University of Paris Cité, INSERM U1151, CNRS UMR 8253, Institut Necker-Enfants Malades, Département Croissance et Signalisation, Paris, France.
  • Jalal Eddine A; Department of Transplantation, Centre Hospitalier Universitaire Necker-Enfants Malades, Paris, France.
  • Gosset C; Department of Nephrology, Centre Hospitalier Universitaire de la Guadeloupe, Pointe-à-Pitre, France.
  • Pourcine F; Department of Nephrology, Hôpital Foch, Paris, France.
  • Zarhrate M; Department of Nephrology, Centre Hospitalier Universitaire de La Réunion, Saint Denis de La Réunion, France.
  • Gibier JB; Department of Nephrology, Centre Hospitalier de Melun, Melun, France.
  • Rensen E; Genomics Core Facility, Structure Fédérative de Recherche Necker, University of Paris, Paris, France.
  • Pietropaoli S; Department of Pathology, Centre Hospitalier Universitaire (CHU) Lille, Lille, France.
  • Barba-Spaeth G; Imaging and Modeling Unit and.
  • Duong-Van-Huyen JP; Structural Virology Unit, Institut Pasteur, Paris, France.
  • Molina TJ; Structural Virology Unit, Institut Pasteur, Paris, France.
  • Mueller F; Department of Pathology, Centre Hospitalier Universitaire Necker-Enfants Malades, Assistance Publique - Hopitaux de Paris (AP-HP), Paris, France.
  • Zimmer C; Department of Pathology, Centre Hospitalier Universitaire Necker-Enfants Malades, Assistance Publique - Hopitaux de Paris (AP-HP), Paris, France.
  • Pontoglio M; Imaging and Modeling Unit and.
  • Terzi F; Imaging and Modeling Unit and.
  • Rabant M; University of Paris Cité, INSERM U1151, CNRS UMR 8253, Institut Necker-Enfants Malades, Département Croissance et Signalisation, Paris, France.
JCI Insight ; 8(5)2023 03 08.
Article en En | MEDLINE | ID: mdl-36749641
ABSTRACT
Acute kidney injury is one of the most important complications in patients with COVID-19 and is considered a negative prognostic factor with respect to patient survival. The occurrence of direct infection of the kidney by SARS-CoV-2, and its contribution to the renal deterioration process, remain controversial issues. By studying 32 renal biopsies from patients with COVID-19, we verified that the major pathological feature of COVID-19 is acute tubular injury (ATI). Using single-molecule fluorescence in situ hybridization, we showed that SARS-CoV-2 infected living renal cells and that infection, which paralleled renal angiotensin-converting enzyme 2 expression levels, was associated with increased death. Mechanistically, a transcriptomic analysis uncovered specific molecular signatures in SARS-CoV-2-infected kidneys as compared with healthy kidneys and non-COVID-19 ATI kidneys. On the other hand, we demonstrated that SARS-CoV-2 and hantavirus, 2 RNA viruses, activated different genetic networks despite triggering the same pathological lesions. Finally, we identified X-linked inhibitor of apoptosis-associated factor 1 as a critical target of SARS-CoV-2 infection. In conclusion, this study demonstrated that SARS-CoV-2 can directly infect living renal cells and identified specific druggable molecular targets that can potentially aid in the design of novel therapeutic strategies to preserve renal function in patients with COVID-19.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: JCI Insight Año: 2023 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: JCI Insight Año: 2023 Tipo del documento: Article País de afiliación: Francia